ReShape Lifesciences Inc. (RSLS) Reports Q2 Net Loss of $7.8M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. INSP
9. CVI
10. HNGE

Go back to ReShape Lifesciences Inc. (RSLS) Reports Q2 Net Loss of $7.8M

ReShape Lifesciences™ Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 15, 2022 4:05 PM EDT

Second Quarter Revenues Increased 19% Sequentially, Indicating DTC Campaign Continues to Drive Demand for Lap-Band® Procedures

Conference Call to be Held at 4:30 pm ET Today

SAN CLEMENTE, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today... More